Megestrol Acetate Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 20 mg, 40 mg, 160 mg, 625 mg
Reference Brands: Megace(US & EU), Megestat®, Megaplex®, Megacephin®(EU)
Category:
Oncology Cancer Care
Megestrol Acetate Tablets are used in oncology to treat advanced breast and endometrial cancers and manage cancer-related cachexia. Available in strengths like 20 mg, 40 mg, 160 mg, and 625 mg, they are widely used across the U.S. and EU for hormone-responsive tumors and appetite stimulation.
Megestrol Acetate is available in Tablet
and strengths such as 20 mg, 40 mg, 160 mg, 625 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Megestrol Acetate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Megestrol Acetate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Megestrol Acetate Tablets are oral hormone-based therapies widely used in oncology for treating advanced breast and endometrial cancers, as well as cancer-related cachexia. Available in 20 mg, 40 mg, 160 mg, and 625 mg strengths, Megestrol Acetate is approved in both the U.S. and EU markets. It works by modifying hormone levels to inhibit cancer cell growth and stimulate appetite in patients suffering from weight loss. A key product in oncology B2B distribution, Megestrol Acetate is essential for improving quality of life and managing hormone-responsive cancers and cancer-induced anorexia.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing